1
|
Escobar MF, Echavarría MP, Carvajal JA, Lesmes MC, Porras AM, Mesa V, Ávila-Sánchez FA, Gallego JC, Riascos NC, Hurtado D, Fernández PA, Posada L, Hernández AM, Ramos I, Irurita MI, Loaiza JS, Echeverri D, Gonzalez L, Peña-Zárate EE, Libreros-Peña L, Galindo JS, Granados M. Hospital padrino: a collaborative strategy model to tackle maternal mortality: a mixed methods study in a middle-income region. Lancet Reg Health Am 2024; 31:100705. [PMID: 38445021 PMCID: PMC10912672 DOI: 10.1016/j.lana.2024.100705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 02/13/2024] [Accepted: 02/16/2024] [Indexed: 03/07/2024]
Abstract
Background Reducing maternal mortality ratio (MMR) remains a paramount goal for low- and middle-income countries (LMICs), especially after COVID-19's devastating impact on maternal health indicators. We describe our experience implementing the Hospital Padrino Strategy (HPS), a collaborative model between a high-complexity hospital (Fundación Valle del Lili) and 43 medium- and low-complexity hospitals in one Colombian department (an administrative and territorial division) from 2021 to 2022, to sustain the trend towards reducing MMR. The study aimed to assess the effects of implementing HPS on both hospital performance and maternal health indicators in Valle del Cauca department (VCD). Methods A mixed-methods study was conducted, comprising two phases. In the first phase, we investigated a cohort of hospitals through prospective follow-up to assess the outcomes of HPS implementation on hospital performance and maternal health indicators in VCD. In the second phase, qualitative data were collected through focus groups with 131 health workers from 33 hospitals to explore the implications of the HPS implementation on healthcare personnel. All data were obtained from records within the HPS implementation and from the Health Secretary of VCD. Findings Evidence shows that in the context of HPS, 51 workshops involved 980 healthcare workers, covering the entire territory. Substantial improvements were observed in hospital conditions and healthcare personnel's technical competencies when providing obstetric care. Seven hundred eighty-five pregnant women with obstetric or perinatal emergencies received care through telehealth systems, with a progressive increase in technology adoption. Nine percent required Intensive Care Unit (ICU) admission, and none died. The MMR decreased from 78.8 in 2021 to 12.0 cases per 100,000 live births by 2022. Improvements in indicators and conducted training sessions instilled confidence and empowerment among the healthcare teams in the sponsored hospitals, as evidenced in focus groups derived from a sample of 131 healthcare workers from 33 hospitals. Interpretation Implementing the Hospital Padrino Strategy led to a significant MMR reduction, and consolidated a model of social healthcare innovation replicable in LMICs. Funding The Hospital Padrino Strategy was funded by the Fundación Valle del Lili and the Health Secretary of Valle del Cauca. Furthermore, this study received funding from a general grant for research from Tecnoquimicas S.A.
Collapse
Affiliation(s)
- María Fernanda Escobar
- Unidad de Equidad Global en Salud, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - María Paula Echavarría
- Unidad de Equidad Global en Salud, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - Javier Andrés Carvajal
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
| | | | | | - Viviana Mesa
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - Fernando A Ávila-Sánchez
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - Juan Carlos Gallego
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - Natalia C Riascos
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - David Hurtado
- Departamento de Ginecología y Obstetricia, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - Paula A Fernández
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | - Leandro Posada
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | | | - Isabella Ramos
- Facultad de Ciencias de la Salud, Universidad Icesi, Calle 18 No. 122-135, Cali, Colombia
| | | | | | - Daniel Echeverri
- Fundación para el Desarrollo Integral del Pacífico - Propacífico, Cali, Colombia
| | - Luisa Gonzalez
- Unidad de Responsabilidad Social, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
| | - Evelyn Elena Peña-Zárate
- Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
| | - Laura Libreros-Peña
- Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
| | - Juan Sebastián Galindo
- Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
| | - Marcela Granados
- Subdirección General, Fundación Valle del Lili, Cra. 98 no. 18-49, Cali 760032, Colombia
| |
Collapse
|
3
|
Cadranel JF, Dumont M, Mesa V, Degott C, Taillandier J, Erlinger S. [Effect of chronic administration of cyclosporin A on choleresis in rats]. Gastroenterol Clin Biol 1989; 13:779-82. [PMID: 2591685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The effect of therapeutic doses of cyclosporine A (CyA) on bile flow and bile salt output was studied in the rat. Thirty male Sprague-Dawley rats (250 to 380 g) were injected intraperitoneally with CyA (n = 15) or vehicle (n = 15) at the dose of 10 mg.kg-1 for 3 weeks. The effect of CyA on basal and taurocholate-induced bile flow, on basal bile salt output and bile salt output under taurocholate infusion, and the effect of chronic administration of CyA on bile salt-independent bile flow was evaluated. Administration of CyA was associated with a decrease in basal bile flow (5.6 +/- 0.7 vs 6.7 +/- 0.7 microliters.min-1.100 g-1; p less than 0.001) and bile flow under taurocholate infusion (8.0 +/- 0.8 vs 10.9 +/- 1.1 microliters.min-1.100 g-1; p less than 0.001). Basal bile salt output (133.9 +/- 48.2 vs 173.8 +/- 53.6 nmol.min-1.100 g-1; p less than 0.003) and bile salt output under the infusion of taurocholate were significantly lower in cyclosporine-treated rats than in controls (443.3 +/- 48.2 vs 617.2 +/- 172.7 nmol.min-1.100 g-1; p less than 0.001). There was no significant difference in bile salt-independent bile flow between the 2 groups. There was no modification of seric alanine aminotransferase activity or hepatic histology. This study confirms that chronic administration of CyA at therapeutic doses can induce cholestasis. Cholestasis is related mainly to a decrease in bile salt secretion and bile salt-dependent flow.
Collapse
Affiliation(s)
- J F Cadranel
- Unité de Recherches de Physiopathologie Hépatique, INSERM U 24, Clichy
| | | | | | | | | | | |
Collapse
|